Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Healing, Recovery & Immune · Washington, DC
LL-37 is documented by ReVia for Washington research institutions as a human cathelicidin antimicrobial peptide studied for broad-spectrum pathogen defense and immune modulation. Supporting investigators throughout the capital region and nearby Arlington and Alexandria, this compound is supplied for laboratory and research use only with third-party COA verification. Each vial arrives with independent quality documentation suited to DC's demanding research standards.
The sole human cathelicidin-derived antimicrobial peptide. Studies have investigated its broad-spectrum antimicrobial activity, immunomodulatory functions, and role in innate immune defense.
In the capital region's science-forward market, LL-37 is widely referenced as a cathelicidin host-defense peptide for in-vitro antimicrobial and innate-immunity research. Laboratories across Washington, DC, and neighboring Arlington, Alexandria, and Bethesda examine its membrane interactions and peptide structure under controlled conditions, treating the molecule purely as a preclinical study subject within the area's dense institutional research network.
LL-37 is worked with by researchers throughout the Washington metro — including Arlington, Alexandria, Bethesda, Silver Spring — and across East Coast. The capital region's science-forward market. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Washington, DC area obtain LL-37?
LL-37 is supplied through i2b Health, ReVia's research partner, to researchers in Washington and surrounding communities including Alexandria and Bethesda. All supply is designated for research use only.
Is there a third-party COA for LL-37?
Each lot is independently tested and includes a third-party Certificate of Analysis verifying purity and identity. This documentation reflects the standards expected by capital-region laboratories.
What is LL-37 researched for?
LL-37 is studied for broad-spectrum pathogen defense, immune modulation, and wound-healing pathways in research models. It is intended exclusively for laboratory use, not for human or therapeutic purposes.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.